May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Progression of the VLDLR –/– Retinal Phenotype With Age: Correlating Fundus Features With Histological and Functional Measures
Author Affiliations & Notes
  • J. Lee
    UC Berkeley School of Optometry and Helen Wills Neuroscience Institute, Berkeley, CA
  • N. Walsh
    UC Berkeley School of Optometry and Helen Wills Neuroscience Institute, Berkeley, CA
  • I.R. Zolfaghar
    UC Berkeley School of Optometry and Helen Wills Neuroscience Institute, Berkeley, CA
  • C. Xia
    UC Berkeley School of Optometry and Vision Science, Berkeley, CA
  • X. Gong
    UC Berkeley School of Optometry and Vision Science, Berkeley, CA
  • J.G. Flannery
    UC Berkeley School of Optometry and Helen Wills Neuroscience Institute, Berkeley, CA
  • Footnotes
    Commercial Relationships  J. Lee, None; N. Walsh, None; I.R. Zolfaghar, None; C. Xia, None; X. Gong, None; J.G. Flannery, None.
  • Footnotes
    Support  NEI/NIH EY013533 and The Foundation Fighting Blindness
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 5251. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Lee, N. Walsh, I.R. Zolfaghar, C. Xia, X. Gong, J.G. Flannery; Progression of the VLDLR –/– Retinal Phenotype With Age: Correlating Fundus Features With Histological and Functional Measures . Invest. Ophthalmol. Vis. Sci. 2005;46(13):5251.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: The VLDLR –/– mouse provides an important model of subretinal neovascularization through which therapies for human disease may be trialed. We have sought to characterize the retinal features of this strain over a one year period through a range of measures which include fundus imaging, fluorescein angiography, histology, electrophysiology and 3D vessel reconstruction. Methods: Developmental series of fundus and fluorescein angiography (FA) images were taken from VLDLR mice between the ages of 1 and 12 months. Images were analyzed for the characteristic ‘yellow spots’ found in this strain along with the number of leaky foci present at each time point. Histological sections and electrophysiology were taken from wild type and VLDLR mice at 3, 6 and 12 months.Three–dimensional reconstructions of retinal flat mounts were performed following perfusion of animals with a lipophilic vessel dye, and quantitative measurements of vessel length and volume were computed from these reconstructions. Results: At the earliest time point examined, leaky foci evident on FA corresponded to the areas of hypopigmentation observed on color fundus images. An increase in the number of leaky foci was observed up until approximately 10 weeks of age, after which most if not all leaky spots were observed to spontaneously resolve. Areas of hypopigmentation were observed to increase and persist up until the oldest ages studied. Over the one year period, outer nuclear layer thickness was observed to decline and outer segments structure was disrupted. At 3 months of age, measures of a– and b–wave amplitude were not significantly different from age–matched wild type mice. At 6 and 12 months of age, b–wave amplitudes were not significantly different from either the 3 month or control values, and a 40% reduction in a–wave amplitude was observed. Conclusions: Histological sections and 3D vessel reconstruction at the later time points argue against a spontaneous resolution of the vessels, but rather a maturation of the existing vessels. Degeneration of the photoreceptor layer with age is reflected by a reduction in outer nuclear layer thickness and a significant reduction in a–wave amplitude at the 6 and 12 month time points. These results contribute to our understanding of VLDLR phenotype which is important in evaluating therapeutic modalities for retinal neovascularization.

Keywords: retinal neovascularization • degenerations/dystrophies • transgenics/knock-outs 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×